Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
The Journal of Molecular Diagnostics : JMD|November 4, 2018
Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation SequencingJeong E Kim, Sung-Min Chun, Yong S Hong, et al.
Investigational New Drugs|June 15, 2012
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: crossover comparisons with intravenous paclitaxelYong Sang Hong, Kyu-pyo Kim, Hyeong-Seok Lim, et al.
Clinical Therapeutics|January 30, 2010
Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteersBo-Hyung Kim, Kwang-Hee Shin, Jaewoo Kim, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2010
Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailabilityKyu-pyo Kim, Min-Hee Ryu, Changhoon Yoo, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
A Trial Activation Initiative to Accelerate Trial Opening in an Academic Medical CenterYun Jung Choi, HyeJung Jeon, Sinae Kim, et al.
Radiology|July 15, 2020
Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk ScoreDong Wook Kim, Seung Soo Lee, Seon-Ok Kim, et al.
Annals of Hematology|May 22, 2013
The role of ¹⁸F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin's lymphoma patientsByeong Seok Sohn, Dok Hyun Yoon, Kyu Pyo Kim, et al.
Cancers|January 9, 2021
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus CisplatinHyehyun Jeong, Jae Ho Jeong, Kyu-Pyo Kim, et al.
Investigational New Drugs|June 17, 2015
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignanciesKyu-pyo Kim, Seong Joon Park, Jeong-Eun Kim, et al.
British Journal of Clinical Pharmacology|August 8, 2009
Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunctionTae-Eun Kim, Bo-Hyung Kim, Jung-Ryul Kim, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
The Journal of Molecular Diagnostics : JMD|November 4, 2018
Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation SequencingJeong E Kim, Sung-Min Chun, Yong S Hong, et al.
Investigational New Drugs|June 15, 2012
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: crossover comparisons with intravenous paclitaxelYong Sang Hong, Kyu-pyo Kim, Hyeong-Seok Lim, et al.
Clinical Therapeutics|January 30, 2010
Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteersBo-Hyung Kim, Kwang-Hee Shin, Jaewoo Kim, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2010
Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailabilityKyu-pyo Kim, Min-Hee Ryu, Changhoon Yoo, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
A Trial Activation Initiative to Accelerate Trial Opening in an Academic Medical CenterYun Jung Choi, HyeJung Jeon, Sinae Kim, et al.
Radiology|July 15, 2020
Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk ScoreDong Wook Kim, Seung Soo Lee, Seon-Ok Kim, et al.
Annals of Hematology|May 22, 2013
The role of ¹⁸F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin's lymphoma patientsByeong Seok Sohn, Dok Hyun Yoon, Kyu Pyo Kim, et al.
Cancers|January 9, 2021
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus CisplatinHyehyun Jeong, Jae Ho Jeong, Kyu-Pyo Kim, et al.
Investigational New Drugs|June 17, 2015
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignanciesKyu-pyo Kim, Seong Joon Park, Jeong-Eun Kim, et al.
British Journal of Clinical Pharmacology|August 8, 2009
Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunctionTae-Eun Kim, Bo-Hyung Kim, Jung-Ryul Kim, et al.
Pageof 22